SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2001 --------------- IMS Health Incorporated ------------------------ (Exact name of registrant as specified in its charter) Delaware 001-14049 06-1506026 - ------------- ------------------------ ---------------- (State of (Commission File Number) (IRS Employer incorporation) Identification No.) 200 Nyala Farms Westport, CT 06880 - ------------------------------------------- ------------- (Address of principal executive offices) (Zip Code) (203) 222-4200 -------------- (Registrant's telephone number, including area code) N/A ------------------------------------------------------------------- (Former name or former address, if changed since last report) Items 1-4. Not Applicable. Item 5. Other Events. ------------ On August 29, 2001, IMS Health Incorporated decided to sell and completed the sale of 1,554,954 shares of Class A common stock of Gartner, Inc. ("Gartner Shares") to Gartner and an aggregate of 5,000,000 Gartner Shares to several institutional investors. IMS Health received aggregate proceeds of $64,762,945, or $9.88 per share, from these sales (IMS Health's original cost basis in these shares was $77.2 million, or $11.78 per share). These sales divest IMS Health of its remaining equity interest in Gartner. The sale of shares to Gartner was part of Gartner's $75 million stock buyback program announced on July 19, 2001. Items 6-9. Not Applicable. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IMS HEALTH INCORPORATED By: /s/ James C. Malone --------------------- Name: James C. Malone Title: Chief Financial Officer Date: August 31, 2001